GLP-1s and the Online Medication Boom: What You Need to Know
LISTEN ON APPLE PODCASTS | LISTEN ON SPOTIFY | LISTEN ON AMAZON MUSIC
The last decade has completely changed how patients access medication. A prescription for hormones or a GLP-1 weight loss drug that once required multiple in-person appointments can now arrive at your door after a fifteen-minute video call — or sometimes with no consultation at all. For patients who have spent years feeling dismissed, undertreated, or simply too busy to navigate a fragmented healthcare system, that kind of access can feel like a lifeline.
But convenience has a cost. And in this episode of Vitals & Values, Dr. David Roden breaks down what patients aren't being told.
The rise of online medication access
Telehealth and direct-to-consumer pharmacy models have exploded in recent years, and hormones and GLP-1 medications like semaglutide are at the center of that growth. Demand has outpaced supply, wait lists have grown, and a parallel market of online clinics and compounding pharmacies has stepped in to fill the gap. On the surface, it looks like the healthcare system finally working for patients. Under the surface, the picture is considerably more complicated.
What compounded medications actually are — and why it matters
When brand-name drugs like Ozempic or Wegovy are in short supply, compounding pharmacies are legally permitted to produce versions of those medications. But compounded drugs are not FDA-approved. They are not held to the same manufacturing standards. And the quality, dosing accuracy, and sterility of compounded products vary in ways that patients have no easy way to evaluate.
Dr. Roden explains the legal framework around compounded medications, where the gray zones lie, and what questions patients should ask before ordering anything online — including what to look for when verifying whether a pharmacy or clinic is operating legitimately.
Hormones are not one-size-fits-all.
Hormone therapy — whether for menopause, thyroid function, or other endocrine conditions — requires ongoing monitoring, dose adjustment, and an understanding of your full health picture. An online clinic that prescribes based on a single intake form and a lab panel doesn't have that context. Dr. Roden discusses why hormone management is one of the areas of medicine where a continuous primary care relationship isn't just preferable — it's protective.
The primary care relationship as a safety net
Much of this episode comes back to a single throughline: the value of a provider who knows you over time. Not just your labs, but your history, your risk factors, your lifestyle, and your goals. Online-only models can fill short-term gaps, but they aren't designed to capture what only becomes visible over years of care.
For patients considering GLP-1 medications or hormone therapy sourced outside of a traditional practice, Dr. Roden outlines what that decision-making process should actually look like — and why starting with a primary care provider remains the safest first step.
What to take away from this episode:
GLP-1 drugs and hormone therapies sourced from online clinics or compounding pharmacies carry legal and safety risks patients are rarely fully informed about
Compounded medications are not FDA-approved, and quality is not guaranteed
Hormone management requires ongoing monitoring that one-time telehealth visits are not designed to provide
A primary care provider who knows your full history is your most valuable healthcare asset — especially when navigating medications with significant systemic effects.
If you are using or considering online medication sources, verify the pharmacy's credentials and bring your full medication list to your next in-person appointment
Subscribe to Vitals & Values for more straight-talk on the healthcare decisions that affect your everyday life. And if you have a provider you trust — a doctor who knows your name and your history — share this episode with someone who doesn't yet.
